Cardiomyopathies. Part I: Classification - Dilated cardiomyopathy;Kardiomyopathien. Teil I: Klassifikation der kardiomyopathien - Dilatative kardiomyopathie

Internist

Volumn 46, Issue 11, 2005, Pages 1245-1258

  Schultheiss, H P ^a   Noutsias, M ^a   Kuhl U ^a   Lassner, D ^b   Gross, U ^b   Poller, W ^a   Pauschinger, M ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b Institut Kardiale Diagnostik und Therapie GmbH   (Germany)

Author keywords

Cardiac dysfunction; Cardiomyopathies; Dilated cardiomyopathy; Hypertrophic cardiomyopathy

Indexed keywords

AMIODARONE; AZATHIOPRINE; CORTICOSTEROID; INTERFERON BETA SERINE;

CLINICAL TRIAL; CONGESTIVE CARDIOMYOPATHY; DEFIBRILLATOR; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; FAMILIAL DISEASE; GENE MUTATION; GENETIC SCREENING; HEART FAILURE; HEART MUSCLE BIOPSY; HUMAN; IMMUNOHISTOLOGY; IMMUNOMODULATION; INFLAMMATORY DISEASE; PATHOPHYSIOLOGY; PROPHYLAXIS; RELATIVE; REVIEW; SUDDEN DEATH; WORLD HEALTH ORGANIZATION;

CARDIOMYOPATHIES; DEATH, SUDDEN, CARDIAC; HEART FAILURE, CONGESTIVE; HUMANS; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES;

EID: 28744444028     PISSN: 00209554     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00108-005-1483-9     Document Type: Review

References (17)

1. Andersson B, Caidahl K, Waagstein F (1995) Idiopathic dilated cardiomyopathy among Swedish patients with congestive heart failure. Eur Heart J 16: 53-60
2. Bardy GH, Lee KL, Mark DB et al. (2005) Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 352: 225-237
3. Chien KR (2003) Genotype, phenotype: upstairs, downstairs in the family of cardiomyopathies. J Clin Invest 111: 175-178
4. D'Ambrosio A, Patti G, Manzoli A, Sinagra G, Di Lenarda A, Silvestri F, Di Sciascio G (2001) The fate of acute myocarditis between spontaneous improvement and evolution to dilated cardiomyopathy: a review. Heart 85: 499-504
5. Frustaci A, Chimenti C, Calabrese F, Pieroni M, Thiene G, Maseri A (2003) Immunosuppressive therapy for active lymphocytic myocarditis: virological and immunologic profile of responders versus nonresponders. Circulation 107: 857-863
6. Hetzer R, Muller JH, Weng YG, Loebe M, Wallukat G (2000) Midterm follow-up of patients who underwent removal of a left ventricular assist device after cardiac recovery from end-stage dilated cardiomyopathy. J Thorac Cardiovasc Surg 120: 843-853
7. Kuhl U, Pauschinger M, Noutsias M et al. (2005) High prevalence of viral genomes and multiple viral infections in the myocardium of adults with "idiopathic" left ventricular dysfunction. Circulation 111: 887-893
8. Kuhl U, Pauschinger M, Schwimmbeck PL et al. (2003) Interferon-beta treatment eliminates cardiotropic viruses and improves left ventricular function in patients with myocardial persistence of viral genomes and left ventricular dysfunction. Circulation 107: 2793-2798
9. Mahon NG, Madden BP, Caforio AL et al. (2002) Immunohistologic evidence of myocardial disease in apparently healthy relatives of patients with dilated cardiomyopathy. J Am Coll Cardiol 39: 455-462
10. Noutsias M, Seeberg B, Schultheiss HP, Kuhl U (1999) Expression of cell adhesion molecules in dilated cardiomyopathy: evidence for endothelial activation in inflammatory cardiomyopathy. Circulation 99: 2124-2131
11. Pauschinger M, Doerner A, Kuehl U, Schwimmbeck PL, Poller W, Kandolf R, Schultheiss HP (1999) Enteroviral RNA replication in the myocardium of patients with left ventricular dysfunction and clinically suspected myocarditis. Circulation 99: 889-895
12. Richardson P, McKenna W, Bristow M et al. (1996) Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the definition and classification of cardiomyopathies. Circulation 93: 841-842
13. Staudt A, Schaper F, Stangl V et al. (2001) Immunohistological changes in dilated cardiomyopathy induced by immunoadsorption therapy and subsequent immunoglobulin substitution. Circulation 103: 2681-2686
14. Staudt A, Staudt Y, Dorr M et al. (2004) Potential role of humoral immunity in cardiac dysfunction of patients suffering from dilated cardiomyopathy. J Am Coll Cardiol 44: 829-836
15. Sugrue DD, Rodeheffer RJ, Codd MB, Ballard DJ, Fuster V, Gersh BJ (1992) The clinical course of idiopathic dilated cardiomyopathy. A population-based study. Ann Intern Med 117: 117-123
16. Tschope C, Bock CT, Kasner M et al. (2005) High prevalence of cardiac parvovirus B19 infection in patients with isolated left ventricular diastolic dysfunction. Circulation 111: 879-886
17. Wojnicz R, Nowalany-Kozielska E, Wojciechowska C et al. (2001) Randomized, placebo-controlled study for immunosuppressive treatment of inflammatory dilated cardiomyopathy: two-year follow-up results. Circulation 104: 39-45